Skip to main content
SpringerLink
Log in
Book cover

Image Guided Prostate Cancer Treatments pp 255–261Cite as

High-Intensity Focused Ultrasound for the Treatment of Prostate Cancer

  • Chapter
  • First Online:

Abstract

High-intensity focused ultrasound (HIFU) is an emerging noninvasive, local treatment for prostate cancer with 17 years of clinical experience during which approximately 50,000 HIFU treatments have been performed worldwide. The premise behind HIFU is the destruction of tissue by depositing large amounts of energy into it. Ultrasound waves deposit energy as they travel through tissue, but the amount of energy deposited during traditional, diagnostic ultrasound imaging is insignificant (Woodward and Warwick 1970). Ablating with ultrasound is accomplished by doing two things: increasing the intensity of the waves and focusing the waves on a focal point. When performed appropriately, it will raise the temperature of tissue to a level sufficient to cause irreversible damage (cell kill) in a discrete volume of tissue (Wu et al. 2001).

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   149.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Ahmed HU, Hindley RG, Dickinson L, Freeman A, Kirkham AP, Sahu M, Scott R, Allen C, Van der Meulen J, Emberton M. Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study. Lancet Oncol. 2012;13(6):622–32.

    Article  PubMed  Google Scholar 

  • American Cancer Society. Cancer facts & figs. 2013. Atlanta: American Cancer Society; 2013.

    Google Scholar 

  • Barnett SB, ter Haar GR, Ziskin MC, Nyborg WL, Maeda K, Bang J. Current status of research on biophysical effects of ultrasound. Ultrasound Med Biol. 1994;20(3):205–18.

    Article  CAS  PubMed  Google Scholar 

  • Boorjian SA, Karnes RJ, Rangel LJ, Bergstralh EJ, Blute ML. Mayo Clinic validation of the D’amico risk group classification for predicting survival following radical prostatectomy. J Urol. 2008;179(4):1354–60.

    Article  PubMed  Google Scholar 

  • Chaussy CG, Thüroff SF. Robotic high-intensity focused ultrasound for prostate cancer: what have we learned in 15 years of clinical use? Curr Urol Rep. 2011;12(3):180–7.

    Article  PubMed  Google Scholar 

  • Crouzet S, et al. Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncologic outcomes and morbidity in 1002 patients. Eur Urol. 2013;91:66–79. In press.

    Google Scholar 

  • Curiel L, Chavrier F, Gignoux B, Pichardo S, Chesnais S, Chapelon JY. Experimental evaluation of lesion prediction modelling in the presence of cavitation bubbles: intended for high-intensity focused ultrasound prostate treatment. Med Biol Eng Comput. 2004;42:44–54.

    Article  CAS  PubMed  Google Scholar 

  • Ganzer R, Fritsche HM, Brandtner A, Bründl J, Koch D, Wieland WF, Blana A. 14-year oncologic and functional outcome of high-intensity focused ultrasound (HIFU) in localized prostate cancer. BJU Int. 2013;112(3):322–9.

    Google Scholar 

  • Gelet A, Chapelon JY, Bouvier R, Souchon R, Pangaud C, Abdelrahim AF, Cathignol D, Dubernard JM. Treatment of prostate cancer with transrectal focused ultrasound: early clinical experience. Eur Urol. 1996;29(2):174–83.

    CAS  PubMed  Google Scholar 

  • Hill CR, ter Haar GR. High intensity focused ultrasound–potential for cancer treatment. Br J Radiol. 1995;68(816):1296–303.

    Article  CAS  PubMed  Google Scholar 

  • Linke CA, Carstensen EL, Frizzell LA, Elbadawi A, Fridd CW. Localized tissue destruction by high-intensity focused ultrasound. Arch Surg. 1973;107(6):887–91.

    Article  CAS  PubMed  Google Scholar 

  • Rebillard X, Villers A, et al. Comité de Cancérologie de l’AFU. Recommandations 2002 sur le cancer de prostate. Prog Urol. 2002;12:31–67.

    Google Scholar 

  • Soloway M, Roach III M. Prostate cancer progression after therapy of primary curative intent. A review of data from the prostate-specific antigen era. Cancer. 2005;14(11):2310–22.

    Article  Google Scholar 

  • Stephenson AJ, Kattan MW, Eastham JA, Bianco Jr FJ, Yossepowitch O, Vickers AJ, Klein EA, Wood DP, Scardino PT. Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era. J Clin Oncol. 2009;27(26):4300–5.

    Article  PubMed  Google Scholar 

  • Thüroff S, Chaussy C. Evolution and outcomes of 3 MHz high intensity focused ultrasound therapy for localized prostate cancer during 15 years. J Urol. 2013;190(2):702–10.

    Google Scholar 

  • Woodward B, Warwick R. How safe is diagnostic sonar? Br J Radiol. 1970;43(514):719–25.

    Article  CAS  PubMed  Google Scholar 

  • Wu F, Chen WZ, Bai J, Zou JZ, Wang ZL, Zhu H, Wang ZB. Pathological changes in human malignant carcinoma treated with high-intensity focused ultrasound. Ultrasound Med Biol. 2001;27(8):1099–106.

    Article  CAS  PubMed  Google Scholar 

  • Yang R, Sanghvi NT, Rescorla FJ, Kopecky KK, Grosfeld JL. Liver cancer ablation with extracorporeal high-intensity focused ultrasound. Eur Urol. 1993;23 Suppl 1:17–22.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. USC Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA

    John C. Rewcastle PhD & Inderbir S. Gill MD

Authors
  1. John C. Rewcastle PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Inderbir S. Gill MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John C. Rewcastle PhD .

Editor information

Editors and Affiliations

  1. Biofoundation for angiogenesis Research and Development, Bard Cancer Center, New York, New York, USA

    Robert L. Bard

  2. Department of Radiology, Radboud University Medical Centre, HB Nijmegen, The Netherlands

    Jurgen J. Fütterer

  3. Sperling Prostate Center, Carlstadt, New Jersey, USA

    Dan Sperling

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Rewcastle, J.C., Gill, I.S. (2014). High-Intensity Focused Ultrasound for the Treatment of Prostate Cancer. In: Bard, R., Fütterer, J., Sperling, D. (eds) Image Guided Prostate Cancer Treatments. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-40429-0_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-40429-0_22

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-40428-3

  • Online ISBN: 978-3-642-40429-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation